Literature DB >> 12039663

Cardiac response to norepinephrine and sympathetic nerve stimulation following experimental subarachnoid hemorrhage.

Elisabeth Lambert1, Xiao-Jun Du, Elodie Percy, Gavin Lambert.   

Abstract

This study aimed to investigate the cardiac response to sympathetic stimulation and norepinephrine exposure following subarachnoid hemorrhage (SAH). Cardiac functional response was assessed 3 days following an injection of 300 microl of homologous blood in the cisterna magna using an in situ perfused, innervated rat heart model. Sympathetic nervous activity was indirectly assessed from measurements of arterial plasma and tissue norepinephrine concentration and cardiac beta-receptor density. In in situ perfused hearts, sympathetic nerve stimulation (2, 4 and 8 Hz, 1 min duration) induced a frequency-dependent increase in left ventricular pressure (VP), with the response being more pronounced in the SAH group of animals at the higher frequency (P<0.05). However, the concomitant release of norepinephrine was identical in the two groups of animals. Increasing doses of norepinephrine (10(-9) to 10(-5) M) added to the perfusate induced a dose-dependent increase in VP and its first derivative (dP/dt). Both responses were greater in the SAH animals compared to the sham rats (P<0.01). ECG recordings from SAH animals presented a higher incidence of different types of arrhythmias, both at rest and when submitted to electrical stimulation or norepinephrine exposure. No difference was found between groups in left ventricle norepinephrine content, plasma norepinephrine nor left ventricle beta-receptor density. In conclusion, hearts from animals following acute experimental SAH exhibit enhanced sensitivity to norepinephrine infusion and sympathetic nerve stimulation, and are more prone to develop arrhythmias. However, hypersensitivity of the heart may not be explained by changes in norepinephrine release or by beta-receptor density.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039663     DOI: 10.1016/s0022-510x(02)00073-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Hypertension After Severe Traumatic Brain Injury: Friend or Foe?

Authors:  Vijay Krishnamoorthy; Nophanan Chaikittisilpa; Taniga Kiatchai; Monica Vavilala
Journal:  J Neurosurg Anesthesiol       Date:  2017-10       Impact factor: 3.956

Review 2.  Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage.

Authors:  Vivien H Lee; Jae K Oh; Sharon L Mulvagh; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Ventricular arrhythmia risk after subarachnoid hemorrhage.

Authors:  J Michael Frangiskakis; Marilyn Hravnak; Elizabeth A Crago; Masaki Tanabe; Kevin E Kip; John Gorcsan; Michael B Horowitz; Amin B Kassam; Barry London
Journal:  Neurocrit Care       Date:  2009-01-28       Impact factor: 3.210

4.  Cardiac troponin I elevation in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Ik-Chan Jeon; Chul-Hoon Chang; Byung-Yon Choi; Min-Su Kim; Sang-Woo Kim; Seong-Ho Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-08-31

5.  Neurogenic cardiopulmonary complications associated with spontaneous cerebellar hemorrhage.

Authors:  Yui-Rwei Young; Chien-Chang Lee; Bor-Fuh Sheu; Shy-Shin Chang
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 6.  Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going?

Authors:  Vijay Krishnamoorthy; G Burkhard Mackensen; Edward F Gibbons; Monica S Vavilala
Journal:  Chest       Date:  2015-12-28       Impact factor: 9.410

7.  The relationship between the time of cerebral desaturation episodes and outcome in aneurysmal subarachnoid haemorrhage: a preliminary study.

Authors:  Małgorzata Burzyńska; Agnieszka Uryga; Magdalena Kasprowicz; Marek Czosnyka; Barbara Dragan; Andrzej Kübler
Journal:  J Clin Monit Comput       Date:  2019-08-20       Impact factor: 2.502

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.